Summit Wealth Group (Colorado)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$743K Sell
5,779
-556
-9% -$65.1K 0.06% 163
2026
Q1
$762K Buy
6,335
+1,379
+28% +$159K 0.08% 133
2025
Q4
$522K Sell
4,956
-9,275
-65% -$871K 0.07% 139
2025
Q3
$1.47M Buy
14,231
+9,491
+200% +$782K 0.16% 116
2025
Q2
$379K Buy
+4,740
New +$377K 0.1% 157

Other funds holding MRK

Summit Wealth Group (Colorado)'s MRK Position: Q2 2026 in Review

Summit Wealth Group (Colorado) reduced its Merck (MRK) stake by 8.8% in Q2 2026, selling an estimated $65.1K and leaving 5,779 shares worth $743K. The position accounts for 0.06% of the portfolio, ranked #163.

Summit Wealth Group (Colorado) first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.47M in Q3 2025. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Summit Wealth Group (Colorado) held 5,779 shares of Merck worth $743K as of Q2 2026.
  • Summit Wealth Group (Colorado) sold 556 Merck shares in Q2 2026, an estimated $65.1K.
  • Merck made up 0.06% of Summit Wealth Group (Colorado)'s portfolio in Q2 2026, its #163 holding.
  • Summit Wealth Group (Colorado) first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • Summit Wealth Group (Colorado)'s Merck position peaked at $1.47M in Q3 2025.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q2 2026, filed 28 Jul 2026.